Comparing two drugs carbetocin and oxytocin in prevention of postpartum hemorrhage in a randomly selected deliveries in mother hospital. Oxytocin is routinely used drug instead of which we are using carbetocin also in selected patients and comparing their efficacies
Phase 4
- Conditions
- Health Condition 1: O720- Third-stage hemorrhage
- Registration Number
- CTRI/2022/11/047176
- Lead Sponsor
- DR BINDHU VARGHESE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
SINGLETON PREGNANCIES
-UNCOMPLICATED
-TERM(37-42wks)
-SPONTANEOUS OR INDUSED
-LSCS OR VAGINAL DELIVERIES
Exclusion Criteria
-H/O PPH
-RISK FACTORS FOR PPH
-UTERINE OVERDISTENSION AS IN TWINS, POLYHYDRAMNIOS, FETAL MACROSOMIA
-MATERNAL COMPLICATIONS LIKE HEART DISEASE, EPILEPSY
-GENERAL ANESTHESIA
-APH
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare efficacy of oxytocin vs carbetocin in prevention of PPH by comparing need of additional uterotonics among both drugsTimepoint: Within 24 hours
- Secondary Outcome Measures
Name Time Method To compare amount of blood loss and Hb deficit among both drugsTimepoint: Within 24 hrs of delivery